Molecular findings in maxillofacial bone tumours and its diagnostic value.
Ontology highlight
ABSTRACT: According to the WHO, mesenchymal tumours of the maxillofacial bones are subdivided in benign and malignant maxillofacial bone and cartilage tumours, fibro-osseous and osteochondromatous lesions as well as giant cell lesions and bone cysts. The histology always needs to be evaluated considering also the clinical and radiological context which remains an important cornerstone in the classification of these lesions. Nevertheless, the diagnosis of maxillofacial bone tumours is often challenging for radiologists as well as pathologists, while an accurate diagnosis is essential for adequate clinical decision-making. The integration of new molecular markers in a multidisciplinary diagnostic approach may not only increase the diagnostic accuracy but potentially also identify new druggable targets
SUBMITTER: Cleven AHG
PROVIDER: S-EPMC6968989 | biostudies-literature | 2020 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA